{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+3&page=44", "query": { "intervention": "Part 3", "page": 44 }, "page_size": 10 }, "pagination": { "page": 44, "page_size": 10, "total_count": 4019, "total_pages": 402, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+3&page=45&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+3&page=43&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T00:34:06.928Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05329103", "title": "A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumor" ], "interventions": [ { "name": "PEEL-224", "type": "DRUG" }, { "name": "FOLF+B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Peel Therapeutics Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 65, "start_date": "2022-07-11", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 8, "location_summary": "Scottsdale, Arizona • Palo Alto, California • Huntersville, North Carolina + 5 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Huntersville", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT05329103" }, { "nct_id": "NCT04711161", "title": "First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ovarian Tumors" ], "interventions": [ { "name": "GRN-300", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Green3Bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 73, "start_date": "2020-12-21", "completion_date": "2025-03", "has_results": false, "last_update_posted_date": "2024-01-23", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04711161" }, { "nct_id": "NCT07849231", "title": "A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Myeloproliferative Neoplasms (MPNs)" ], "interventions": [ { "name": "DMR-001", "type": "DRUG" }, { "name": "Ruxolitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Damora Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2026-09", "completion_date": "2030-06", "has_results": false, "last_update_posted_date": "2026-10-27", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • Duarte, California + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07849231" }, { "nct_id": "NCT03699319", "title": "CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "CPI 613", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "5-flurouracil", "type": "DRUG" }, { "name": "Folinic acid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David Bajor, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 49, "start_date": "2018-12-07", "completion_date": "2024-09-23", "has_results": false, "last_update_posted_date": "2025-01-23", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03699319" }, { "nct_id": "NCT03122119", "title": "Effectiveness of Ultrasound Guided Platelet Rich Plasma Injections in the Sacroiliac Joint", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Low Back Pain", "Sacroiliitis", "Sacroiliac; Backache", "Platelet Rich Plasma", "Platelet", "Injection Site", "Ultrasound Therapy; Complications", "Treatment" ], "interventions": [ { "name": "Platelet Rich Plasma Joint Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Star Spine and Sport", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 51, "start_date": "2017-05-01", "completion_date": "2022-09-01", "has_results": true, "last_update_posted_date": "2023-04-28", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 1, "location_summary": "Golden, Colorado", "locations": [ { "city": "Golden", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03122119" }, { "nct_id": "NCT03752528", "title": "Evaluation of Long-term Buprenorphine Plasma Exposure", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Opioid-use Disorder" ], "interventions": [ { "name": "Blood sample collection", "type": "DIAGNOSTIC_TEST" }, { "name": "Urine sample collection", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Indivior Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 53, "start_date": "2019-02-19", "completion_date": "2019-07-18", "has_results": true, "last_update_posted_date": "2020-08-21", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 11, "location_summary": "Hamilton, Alabama • Tampa, Florida • Prairie Village, Kansas + 7 more", "locations": [ { "city": "Hamilton", "state": "Alabama" }, { "city": "Tampa", "state": "Florida" }, { "city": "Prairie Village", "state": "Kansas" }, { "city": "Watertown", "state": "Massachusetts" }, { "city": "Berlin", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03752528" }, { "nct_id": "NCT01495065", "title": "A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Community-acquired Infection" ], "interventions": [ { "name": "GSK2251052 750 mg", "type": "DRUG" }, { "name": "GSK2251052 1500 mg", "type": "DRUG" }, { "name": "GSK2251052 1500 mg BID", "type": "DRUG" }, { "name": "GSK2251052 2250 mg", "type": "DRUG" }, { "name": "GSK2251052 3000 mg", "type": "DRUG" }, { "name": "GSK2251052 0.9% saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 8, "start_date": "2011-12-19", "completion_date": "2012-02-17", "has_results": false, "last_update_posted_date": "2017-06-15", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01495065" }, { "nct_id": "NCT06611436", "title": "BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hemophilia B", "Hemophilia B, Moderately Severe or Severe" ], "interventions": [ { "name": "BE-101", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Be Biopharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 5, "start_date": "2024-12-04", "completion_date": "2026-05-29", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 5, "location_summary": "Davis, California • Washington D.C., District of Columbia • Ann Arbor, Michigan + 2 more", "locations": [ { "city": "Davis", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06611436" }, { "nct_id": "NCT07174336", "title": "A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Neoplasms", "Neoplasm Metastasis" ], "interventions": [ { "name": "LY4064809", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Ribociclib", "type": "DRUG" }, { "name": "Palbociclib", "type": "DRUG" }, { "name": "Abemaciclib", "type": "DRUG" }, { "name": "Anastrozole", "type": "DRUG" }, { "name": "Letrozole", "type": "DRUG" }, { "name": "Exemestane", "type": "DRUG" }, { "name": "Fulvestrant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 800, "start_date": "2025-12-22", "completion_date": "2033-05", "has_results": false, "last_update_posted_date": "2026-11-04", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 132, "location_summary": "Anchorage, Alaska • Chandler, Arizona • Phoenix, Arizona + 112 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07174336" }, { "nct_id": "NCT07161544", "title": "A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Stargardt Disease" ], "interventions": [ { "name": "AAVB-039", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "AAVantgarde Bio Srl", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "8 Years to 55 Years" }, "enrollment_count": 75, "start_date": "2025-09-29", "completion_date": "2032-07", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-11-12T00:34:06.928Z", "location_count": 8, "location_summary": "Phoenix, Arizona • Los Angeles, California • Jacksonville, Florida + 4 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07161544" } ] }